Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma.
Authors
Navid, Fariba; Sondel, Paul M.; Barfield, Raymond; Shulkin, Barry L.; Kaufman, Robert A.; Allay, Jim A.; Gan, Jacek; Hutson, Paul; Songwon Seo; KyungMann Kim; Goldberg, Jacob; Hank, Jacquelyn A.; Billups, Catherine A.; Jianrong Wu; Furman, Wayne L.; McGregor, Lisa M.; Otto, Mario; Gillies, Stephen D.; Handgretinger, Rupert; Santana, Victor M.
Publication
Journal of Clinical Oncology, 2014, Vol 32, Issue 14, p1445